Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.60
-0.12 (-1.38%)
Last updated: Jul 28, 2026, 10:02 AM CET
Svas Biosana Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46 | 42 | 38 | 43 | 53 | - | |
Market Cap Growth | 4.27% | 10.72% | -11.88% | -19.13% | - | - |
Enterprise Value | 84.62 | 4.65 | 0.45 | 70.12 | 78.83 | 0 |
Last Close Price | 8.60 | 8.00 | 7.10 | 8.00 | 9.80 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.74 | 6.19 | 6.44 | 8.38 | 14.87 | - |
Forward PE | 6.87 | 5.59 | 5.92 | 8.56 | 10.60 | - |
PS Ratio | 0.32 | 0.30 | 0.31 | 0.35 | 0.52 | - |
PB Ratio | 0.67 | 0.62 | 0.60 | 0.73 | 0.97 | - |
P/TBV Ratio | 0.92 | 0.86 | 0.74 | 0.90 | 1.22 | - |
P/FCF Ratio | 16.69 | - | - | 82.58 | 27.95 | - |
P/OCF Ratio | 7.09 | - | - | 10.00 | 10.87 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.60 | 0.03 | 0.00 | 0.57 | 0.77 | - |
EV/EBITDA Ratio | 5.63 | 0.38 | 0.05 | 5.16 | 7.14 | - |
EV/EBIT Ratio | 6.91 | 0.38 | 0.05 | 8.18 | 12.60 | - |
EV/FCF Ratio | 31.01 | - | - | 134.87 | 41.51 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 0 | 0 | 1.10 | 0.97 | 1.02 |
Debt / EBITDA Ratio | - | - | - | 4.95 | 5.00 | 5.27 |
Debt / FCF Ratio | - | - | - | 129.22 | 29.10 | - |
Net Debt / Equity Ratio | -0.56 | -0.56 | -0.59 | 0.46 | 0.47 | 0.46 |
Net Debt / EBITDA Ratio | -2.49 | -3.05 | -3.81 | 2.00 | 2.33 | 2.26 |
Net Debt / FCF Ratio | 5.90 | - | - | 52.27 | 13.55 | -278.79 |
Asset Turnover | 0.81 | 0.80 | 0.73 | 0.78 | 0.73 | 0.67 |
Inventory Turnover | 2.83 | 2.83 | 2.71 | 2.94 | 2.74 | 2.33 |
Quick Ratio | 57.22 | 57.22 | 2.91 | 1.36 | 1.27 | 1.33 |
Current Ratio | 82.05 | 82.05 | 4.06 | 1.88 | 1.80 | 1.85 |
Return on Equity (ROE) | 5.35% | 10.38% | 9.65% | 9.03% | 6.77% | 8.03% |
Return on Assets (ROA) | 5.17% | 5.17% | 4.34% | 4.14% | 3.40% | 3.72% |
Return on Invested Capital (ROIC) | 30.06% | 32.61% | 12.89% | 7.76% | 6.21% | 6.41% |
Return on Capital Employed (ROCE) | 7.69% | 7.69% | 8.33% | 9.09% | 7.18% | 8.14% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 14.87% | 16.16% | 15.53% | 11.93% | 6.72% | - |
FCF Yield | 5.99% | 0.00% | 0.00% | 1.21% | 3.58% | - |
Dividend Yield | 2.29% | 3.16% | 4.23% | 0.00% | 0.00% | - |
Payout Ratio | 19.56% | 19.56% | 27.24% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | 1.74% | 1.74% | 0.71% | 0.93% | -40.33% | - |
Total Shareholder Return | 4.04% | 4.90% | 4.94% | 0.93% | -40.33% | - |